Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-22

Clinical Trial Update: Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar [Phase 2]

View source ↗

Summary

A Phase 2 study in inoperable non-metastatic pancreatic cancer (Stage IVA) evaluated neoadjuvant GTX with radiation and gemcitabine (Gemzar); results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemzar (gemcitabine)

Snippet

Sponsor: Columbia University | Conditions: Pancreatic Cancer Stage IVA | Phase 2 | Status: COMPLETED | Results posted: 2016-06-22